KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to 0.07%.

  • Emergent BioSolutions' Return on Invested Capital rose 2100.0% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year increase of 2100.0%. This contributed to the annual value of 0.11% for FY2024, which is 2400.0% up from last year.
  • Emergent BioSolutions' Return on Invested Capital amounted to 0.07% in Q3 2025, which was up 2100.0% from 0.06% recorded in Q2 2025.
  • Emergent BioSolutions' Return on Invested Capital's 5-year high stood at 0.17% during Q1 2021, with a 5-year trough of 0.49% in Q4 2023.
  • For the 5-year period, Emergent BioSolutions' Return on Invested Capital averaged around 0.09%, with its median value being 0.06% (2022).
  • In the last 5 years, Emergent BioSolutions' Return on Invested Capital tumbled by -4700bps in 2023 and then soared by 3900bps in 2025.
  • Emergent BioSolutions' Return on Invested Capital (Quarter) stood at 0.1% in 2021, then crashed by -163bps to 0.06% in 2022, then crashed by -668bps to 0.49% in 2023, then skyrocketed by 75bps to 0.12% in 2024, then soared by 156bps to 0.07% in 2025.
  • Its Return on Invested Capital stands at 0.07% for Q3 2025, versus 0.06% for Q2 2025 and 0.17% for Q1 2025.